Analystreport

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target lowered by analysts at Guggenheim from $80.00 to $78.00. They now have a "buy" rating on the stock.

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report